Thomas John T. - 18 Jan 2024 Form 4 Insider Report for Physicians Realty Trust

Role
President and CEO, Director
Signature
/s/ Christopher M. Bartoli, as attorney-in-fact
Issuer symbol
N/A
Transactions as of
18 Jan 2024
Net transactions value
-$600,802
Form type
4
Filing time
22 Jan 2024, 17:04:15 UTC
Previous filing
03 Mar 2023
Next filing
04 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DOC Common shares, $0.01 par value Options Exercise +149,881 +25% 743,265 18 Jan 2024 Direct F1, F2
transaction DOC Common shares, $0.01 par value Tax liability $600,802 -46,394 -6.2% $12.95 696,871 18 Jan 2024 Direct
holding DOC Common shares, $0.01 par value 5,217 18 Jan 2024 Represents shares held by the Reporting Person's child F3
holding DOC Common shares, $0.01 par value 217 18 Jan 2024 Represents shares held by the Reporting Person's child
holding DOC Common shares, $0.01 par value 434 18 Jan 2024 Represents shares held by the Reporting Person's child
holding DOC Common shares, $0.01 par value 87 18 Jan 2024 Represents shares held by the Reporting Person's child
holding DOC Common shares, $0.01 par value 87 18 Jan 2024 Represents shares held by the Reporting Person's child
holding DOC Common shares, $0.01 par value 87 18 Jan 2024 Represents shares held by the Reporting Person's child
holding DOC Common shares, $0.01 par value 217 18 Jan 2024 Represents shares held by the Reporting Person's child

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DOC 2021 Performance Based Restricted Share Unit Grant Options Exercise $0 -75,392 -100% $0.000000* 0 18 Jan 2024 Common shares, $0.01 par value 75,392 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents vesting of the 2021 Performance Based Restricted Share Units granted on March 1, 2021 under the Issuer's Equity Incentive Plan (the "Plan"). Subject to the terms of the grant, the Reporting Person received 149,881 common shares upon vesting.
F2 Includes 1,733 shares acquired under the Issuer's Employee Stock Purchase Plan (the "ESPP") on December 29, 2023, 434 shares acquired under the Dividend Reinvestment and Share Purchase Plan, and a 5,000 share transfer to the Reporting Person's child.
F3 Includes shares transferred from the Reporting Person.
F4 On March 1, 2021, the Reporting Person was granted 75,392 performance share units under the Issuer's Plan, which represent the "target" number of shares underlying the performance share units. Subject to the terms of the grant, the Reporting Person received 149,881 common shares upon vesting.